Sektorale Bewertungen Alnylam Pharmaceuticals, Inc.

Aktien

A0CBCK

US02043Q1076

ALNY

Pharmazeutika

Markt geschlossen - Nasdaq 22:00:00 13.01.2025 % 5 Tage % 1. Jan.
258,27 USD +8,53 % Intraday Chart für Alnylam Pharmaceuticals, Inc. +10,77 % +9,76 %
Hauptkonkurrenten
Zu einer Liste hinzufügen
KGV (Y) Price to Book PEG EV / Sales Marktkap. / EBITDA Marktkap. / EBIT Dividendenrendite (Y) Kap. ($)
-118.72x 591,74 2.76x12.92x-375.14x-224.2x-.--%30,69 Mrd.
63.2x 42,40 0.53x16.3x46.04x51.3x+0,65%720 Mrd.
28.25x 19,89 1.4x10.01x20.16x22.6x+1,73%385 Mrd.
20.53x 4,723 -0.41x3.99x11.63x13.1x+3,33%342 Mrd.
38.24x 37,60 0.56x6.54x14.3x14.83x+3,55%310 Mrd.
14.02x 5,315 0x4.28x10.21x11.58x+3,07%251 Mrd.
15.89x 5,977 0.91x3.78x9.87x11.05x+3,69%234 Mrd.
24.21x 5,009 0.53x4.33x13.45x13.54x+2,32%208 Mrd.
18.01x 4,434 -0.79x4.2x10.7x11.18x+3,83%198 Mrd.
15.69x 1,702 0.04x3.33x8.28x10.21x+6,24%151 Mrd.
28.71x 21,68 -1.07x5.74x10.1x12.85x+3,45%141 Mrd.
17.63x 1,571 0.68x2.78x9.32x10.22x+4,01%122 Mrd.
-17.16x 6,137 0.09x3.2x27.58x32.17x+4,28%113 Mrd.
937.32x 5,904 -9.58x4.58x12.21x15.74x+3,41%112 Mrd.
28.71x 5,950 1.54x8.85x17.9x19.31x+1,31%70,24 Mrd.
15.86x 3,738 -0.53x2.21x6.73x7.61x+4,47%67,17 Mrd.
34.71x 4,639 2.54x3.78x20.51x26.41x+1,49%49,16 Mrd.
54.31x 0,9057 -3.09x2.37x10.01x33.66x+4,76%41,39 Mrd.
22.51x 1,999 0.49x3.68x14.7x16.31x+1,68%41,05 Mrd.
Durchschnitt 65,36x 40,6 -0,18x 5,62x -5,34x 5,76x +3,01 % 188,84 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung 57,71x 22,34 0,05x 7,47x 16,62x 20,52x +2,72 %
Pharmazeutika - Andere